This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://dx.doi.org/10.1615/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72774316
rdf:type
wikibase:Item
schema:description
scientific article published on 01 January 1994 artikull shkencor i botuar më 01 janar 1994 artículu científicu espublizáu en xineru de 1994 wetenschappelijk artikel наукова стаття, опублікована в січні 1994
p:P577
wds:Q72774316-C5771A76-BF92-416C-AC72-645602AF741A
wdt:P577
1994-01-01T00:00:00Z
p:P2093
wds:Q72774316-21690A96-87CD-4B57-A423-7793C72AE1EC wds:Q72774316-7A648A3E-026A-425F-8F72-0B6215F57ABD
wdt:P2093
Paweletz N Boxberger HJ
rdfs:label
Defined tumor cell-host interactions are necessary for malignant growth Defined tumor cell-host interactions are necessary for malignant growth Defined tumor cell-host interactions are necessary for malignant growth
skos:prefLabel
Defined tumor cell-host interactions are necessary for malignant growth Defined tumor cell-host interactions are necessary for malignant growth Defined tumor cell-host interactions are necessary for malignant growth
schema:name
Defined tumor cell-host interactions are necessary for malignant growth Defined tumor cell-host interactions are necessary for malignant growth Defined tumor cell-host interactions are necessary for malignant growth
p:P1476
wds:Q72774316-602AD30D-AD71-48B8-904E-7F6B3D20CAAC
wdt:P1476
Defined tumor cell-host interactions are necessary for malignant growth
p:P304
wds:Q72774316-B0614944-7B1D-4CE6-8663-A0476B76A4E9
wdt:P304
69-105
p:P31
wds:Q72774316-BC88D941-8D63-4505-8E02-012A75DB2B19 wds:Q72774316-350aab4c-d2b0-4cae-bade-a59f7f8ef422
wdt:P31
wd:Q13442814 wd:Q7318358
p:P698
wds:Q72774316-6068D4B7-7534-4FE0-BBF8-D2D76F5CF2C8
wdtn:P698
n11:7948109
wdt:P698
7948109
p:P1433
wds:Q72774316-9DFABAF1-9EF8-4E11-9CEC-7E718C2794D2
wdt:P1433
wd:Q5186672
p:P433
wds:Q72774316-DC53D891-C1F0-46BA-A929-6F1429A257DB
p:P478
wds:Q72774316-F7F6F069-9B19-4E80-8154-787F02AC3CC7
wdt:P433
1
wdt:P478
5
p:P356
wds:Q72774316-5ECBF6BE-9D6E-494E-867B-E0AAECF01EE5
wdtn:P356
n8:CRITREVONCOG.V5.I1.40
wdt:P356
10.1615/CRITREVONCOG.V5.I1.40